Harvard-incubated, protein-targeting startup emerges from stealth with $80M

With technology licensed from Harvard Medical School and $80 million to get its lead candidate into the clinic, a Harvard-incubated startup is looking to break new ground. Tectonic Therapeutic, which emerged from stealth on Thursday, is planning on developing drugs targeting novel G-protein-coupled receptors, or GPCRs, a class of cell surface receptors involved in a…

Read More

Op-ed: Celebrate the contributions of Black women

As employers are scrambling to up their diversity and inclusion games, highlighting the accomplishments of Black woman can a tool for corporate and nonprofit boards looking for directors and organizations of all stripes looking to diversify their C-suites. Read More

Read More